Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000005

CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (option exercise)

  • CHIEF SCIENTIFIC OFFICER acquired 23,634 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-06-25 Option exercise 10b5-1 +23,634 $0.34 $8,036 252,594 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-06-25 Conversion 10b5-1 −23,634 228,960 D
Derivatives
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-06-25 Option exercise · Share Option (right to buy) 10b5-1 −23,634 190,166 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-06-25 Conversion · American Depositary Shares 10b5-1 +7,878 7,878 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-06-25 Sale · American Depositary Shares 10b5-1 −7,878 $49.08 $386,646 0 D
Loading xslF345X06/form4-06302026_120631.xml…